Using SOX2+ GBM cell lines, we found that CD11b+ conditioned medium containing type 1 interferon beta (IFNβ) promoted progenitor resistance to ZIKV, whereas inhibition of JAK1/2 signaling restored productive infection. The gene discussed is IFNB1; the disease is glioblastoma.